Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02891824 |
|---|---|
| Brief Title: | ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab (ATALANTE) |
| First Submitted : | May 25, 2016 |
| First Submitted that Met QC Criteria : | September 7, 2016 |
| First Posted : | September 8, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 21, 2021 |
| Last Update Posted : | January 22, 2021 |